INmune Bio Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
18.00
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.52
|
-0.43
|
0.09
|
17.31%
|
|
2022-06-30
|
-0.50
|
-0.38
|
0.12
|
24.00%
|
|
2022-03-31
|
-0.64
|
-0.39
|
0.25
|
39.06%
|
|
2021-12-31
|
-0.58
|
-0.55
|
0.03
|
5.17%
|
|
2021-09-30
|
-0.35
|
-0.55
|
-0.20
|
-57.14%
|
|
2021-06-30
|
-0.34
|
-0.44
|
-0.10
|
-29.41%
|
|
2021-03-31
|
-0.27
|
-0.32
|
-0.05
|
-18.52%
|
|
2020-12-31
|
-0.31
|
-0.26
|
0.05
|
16.13%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.20
|
|
2021-12-31
|
-1.86
|
|
2020-12-31
|
-1.01
|
|
2019-12-31
|
-0.74
|
|
2018-12-31
|
-1.08
|